U.S. pharma giant copyright scrapped two experimental weight loss supplements final yr—a when-daily capsule, lotiglipron, as a result of elevated liver enzymes as well as a two times-day-to-day capsule, danuglipron, as a result of robust Unwanted side effects—but CEO Albert Bourla ha